Mymetics Corp Stock Performance
| MYMX Stock | USD 0 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Mymetics Corp are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Mymetics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Mymetics Corp is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 1.1 M | |
| Total Cashflows From Investing Activities | -10000.00 |
Mymetics |
Mymetics Corp Relative Risk vs. Return Landscape
If you would invest 0.10 in Mymetics Corp on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Mymetics Corp or generate 0.0% return on investment over 90 days. Mymetics Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Mymetics, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Mymetics Corp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mymetics Corp's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Mymetics Corp, and traders can use it to determine the average amount a Mymetics Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MYMX |
Based on monthly moving average Mymetics Corp is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mymetics Corp by adding Mymetics Corp to a well-diversified portfolio.
Mymetics Corp Fundamentals Growth
Mymetics Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Mymetics Corp, and Mymetics Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mymetics Pink Sheet performance.
| Return On Asset | -0.14 | |||
| Operating Margin | (1.76) % | |||
| Current Valuation | 83.16 M | |||
| Shares Outstanding | 303.76 M | |||
| Price To Earning | (2.40) X | |||
| Price To Sales | 12.17 X | |||
| Revenue | 3 K | |||
| EBITDA | (1.96 M) | |||
| Cash And Equivalents | 350 K | |||
| Total Debt | 162 K | |||
| Book Value Per Share | (0.21) X | |||
| Cash Flow From Operations | (1.7 M) | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 7.63 M | |||
| Retained Earnings | (81.98 M) | |||
| Current Asset | 1.38 M | |||
| Current Liabilities | 51.24 M | |||
About Mymetics Corp Performance
Evaluating Mymetics Corp's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Mymetics Corp has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mymetics Corp has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Mymetics Corporation, a vaccine company, engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland. Mymetics Corp operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8 people.Things to note about Mymetics Corp performance evaluation
Checking the ongoing alerts about Mymetics Corp for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Mymetics Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mymetics Corp generated a negative expected return over the last 90 days | |
| Mymetics Corp has some characteristics of a very speculative penny stock | |
| Mymetics Corp has high likelihood to experience some financial distress in the next 2 years | |
| Mymetics Corp currently holds 162 K in liabilities. Mymetics Corp has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Mymetics Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Mymetics Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mymetics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mymetics to invest in growth at high rates of return. When we think about Mymetics Corp's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 3 K. Net Loss for the year was (4.73 M) with loss before overhead, payroll, taxes, and interest of (545 K). | |
| Mymetics Corp currently holds about 350 K in cash with (1.7 M) of positive cash flow from operations. | |
| Roughly 55.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Mymetics Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mymetics Corp's stock is overvalued or undervalued compared to its peers.
- Examining Mymetics Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mymetics Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mymetics Corp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mymetics Corp's pink sheet. These opinions can provide insight into Mymetics Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Mymetics Pink Sheet Analysis
When running Mymetics Corp's price analysis, check to measure Mymetics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mymetics Corp is operating at the current time. Most of Mymetics Corp's value examination focuses on studying past and present price action to predict the probability of Mymetics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mymetics Corp's price. Additionally, you may evaluate how the addition of Mymetics Corp to your portfolios can decrease your overall portfolio volatility.